Simplify Logo

Full-Time

Manager II

Marketing

Confirmed live in the last 24 hours

Tarsus Pharamceuticals

Tarsus Pharamceuticals

201-500 employees

Biopharmaceuticals for eye and infectious diseases

Hardware
Biotechnology

Compensation Overview

$121.5k - $170.1kAnnually

+ Bonus + Stock Equity

Senior, Expert

Irvine, CA, USA

Category
General Marketing
Growth Marketing
Growth & Marketing
Required Skills
Market Research
Sales
Marketing
Requirements
  • Bachelor’s degree in marketing, business, communications, or related field
  • 8+ years relevant experience in healthcare/pharma or general marketing
  • Excellent presentation and communication skills
  • Proven ability to work independently and demonstrate a pro-active approach
  • Team player who is comfortable in a fast-paced start-up company with ambitious goals and timelines
  • Previous agency or agency management experience required
  • Managing processes
  • Self-motivated yet customer-focused
  • Proficient in marketing research and statistical analysis
  • Familiar with financial planning and strategy
Responsibilities
  • Drive Marketing strategy with strong pull-through and execution
  • Identify key knowledge gaps and informational needs to define market research plan
  • Run field advisory board (FAB) team meetings to most effectively capture and respond to field feedback
  • Develop resources for Sales to educate ECPs around prevalence, diagnosis, and treatment.
  • Oversee agency relationships, execution, budget management and yearly performance evaluations of agency of record.
  • Forecast and manage ECP Marketing budget to within 5% of target.
  • Work closely with functional and cross functional teammates to ensure strategic alignment and coordinated efforts.
  • Manage Medical, Legal, Regulatory (MLR) reviews and maintain strong relationships.
  • Grows and maintains relations with ECPs by organizing and developing specific programs, supporting advisory boards, and determining company presence at conferences.
Tarsus Pharamceuticals

Tarsus Pharamceuticals

View

Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution used to treat Demodex Blepharitis, a condition affecting the eyelids. The company also has a pipeline of potential treatments for other conditions, including Lyme Disease Prevention and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong commitment to ethical practices and compliance. The goal of Tarsus Pharmaceuticals is to provide effective medical treatments that improve patient outcomes in areas where there are currently few options.

Company Stage

IPO

Total Funding

$610.6M

Headquarters

Irvine, California

Founded

2017

Growth & Insights
Headcount

6 month growth

5%

1 year growth

12%

2 year growth

192%
Simplify Jobs

Simplify's Take

What believers are saying

  • Securing $200 million in non-dilutive financing from Pharmakon Advisors strengthens Tarsus's financial position, enabling further R&D and market expansion.
  • Positive Phase 2a trial results for TP-05 for Lyme Disease prevention indicate promising future product offerings and potential market growth.
  • Recognition through awards like the Zero to Launch Award highlights Tarsus's innovative approach and successful commercialization strategies.

What critics are saying

  • The biopharmaceutical market is highly competitive and capital-intensive, requiring continuous innovation and substantial investment to maintain a competitive edge.
  • Dependence on the success of a limited number of products, such as XDEMVY, makes the company vulnerable to market fluctuations and regulatory changes.

What makes Tarsus Pharamceuticals unique

  • Tarsus Pharmaceuticals focuses on high unmet medical needs in eye care and infectious diseases, setting it apart from competitors with broader but less specialized portfolios.
  • Their flagship product, XDEMVY, is FDA-approved for treating Demodex Blepharitis, a niche condition with limited treatment options, giving them a unique market position.
  • The company's commitment to ethical operations and robust compliance programs ensures trust and reliability among healthcare providers and patients.